Drugs / shenqifuzheng
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03456609 | Jan 2018 → Dec 2019 | — | Livzon Pharmaceutical Group Inc. | Unknown | No outcome recorded |
| — | NCT03455205 | Dec 2017 → Dec 2019 | — | Livzon Pharmaceutical Group Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | shenqifuzheng | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03456609 ↗ |
| Known as | Shenqifuzheng injection | “observing theShenqifuzheng injection before and after treatment” NCT03455205 ↗ |
| Route | Intravenous | “through intravenous infusion” NCT03455205 ↗ |